Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL741P is a **pseudogene** derived from the 7SL RNA gene, coding for part of the signal recognition particle (SRP) ribonucleoprotein complex[1][3][5][7]. 7SL RNA is essential for SRP function in directing nascent polypeptides to the endoplasmic reticulum[1][8]. However, most 7SL-derived pseudogenes like RN7SL741P are **truncated, non-coding, and not expressed in detectable levels**[3][5][9]; they result from reverse genetic flow from mature 7SL RNA back into DNA and subsequent integration into the genome[3][5][7][9]. Pseudogenes generally lack biological function and are not considered drug targets, though some may have rare regulatory roles as described for other pseudogenes[2][6]. For RN7SL741P in particular, no known biological, disease, or pharmacological roles have been described.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 741, pseudogene (RN7SL741P).